Expertise in
3
conditions

Philipp M. Paprottka

Ismaninger Str. 22, 
Munich, BY, DE 
Expertise in
3
conditions
Ismaninger Str. 22, 
Munich, BY, DE 

Overview

Philipp Paprottka practices practicing medicine in Munich, Germany.

Mr. Paprottka is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Neuroendocrine Tumor, Splenic Infarction, Liver Embolization, and Vertebroplasty.

He is actively involved in clinical research, co-authoring 123 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Ismaninger Str. 22, Munich, BY 81675, Germany
Other Locations
Ismaninger St. 22, Munich, BY 81675, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: May 09, 2025
Intervention Type: Device, Drug
Study Drug: Cisplatin-Gemcitabine
Study Phase: Phase 2/Phase 3

123 Total Publications

Effects of Postinterventional Antithrombotic Use on Transjugular Intrahepatic Portosystemic Shunts: Evaluation of DeGIR Registry Data (Germany, 2021-2024).
Effects of Postinterventional Antithrombotic Use on Transjugular Intrahepatic Portosystemic Shunts: Evaluation of DeGIR Registry Data (Germany, 2021-2024).
Journal: RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
Published: August 26, 2026

Frequently Asked Questions about Philipp M. Paprottka

Is Philipp M. Paprottka a top-rated expert for Liver Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Philipp M. Paprottka is classified as an Advanced expert for Liver Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Philipp M. Paprottka participate in research or clinical trials?

Yes. Philipp M. Paprottka has published 123 articles and abstracts on conditions like Liver Cancer. You can view a list of Philipp M. Paprottka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Paprottka's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile